DCP
TMO icon

DSM Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

DSM Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-142
Closed -$87.8K – 90
2024
Q3 		$87.8K Hold
142
– – ﹤0.01% 51
2024
Q2 		$78.5K Hold
142
– – ﹤0.01% 51
2024
Q1 		$82.5K Sell
142
-135,019
-100% -$75.8M ﹤0.01% 54
2023
Q4 		$71.7M Sell
135,161
-6,626
-5% -$3.21M 1.1% 24
2023
Q3 		$71.8M Sell
141,787
-6,719
-5% -$3.58M 1.21% 25
2023
Q2 		$77.5M Buy
+148,506
New +$80.1M 1.25% 26
2020
Q4 		– Sell
-14,405
Closed -$6.36M – 70
2020
Q3 		$6.36M Sell
14,405
-6,023
-29% -$2.49M 0.07% 32
2020
Q2 		$7.4M Sell
20,428
-105,156
-84% -$35.2M 0.09% 32
2020
Q1 		$35.6M Sell
125,584
-311,200
-71% -$98.1M 0.54% 27
2019
Q4 		$142M Buy
436,784
+10,945
+3% +$3.32M 1.88% 19
2019
Q3 		$124M Sell
425,839
-3,508
-0.8% -$1M 1.91% 19
2019
Q2 		$126M Sell
429,347
-231,524
-35% -$63.8M 1.84% 19
2019
Q1 		$181M Sell
660,871
-33,266
-5% -$8.28M 2.67% 16
2018
Q4 		$155M Sell
694,137
-60,840
-8% -$14.3M 2.68% 16
2018
Q3 		$184M Sell
754,977
-12,559
-2% -$2.89M 2.74% 16
2018
Q2 		$159M Buy
767,536
+59,898
+8% +$12.7M 2.42% 16
2018
Q1 		$146M Buy
707,638
+508,763
+256% +$107M 2.02% 17
2017
Q4 		$37.8M Buy
+198,875
New +$38.1M 0.53% 27

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DSM Capital Partners's TMO Position: Q4 2024 in Review

DSM Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 142 shares — an estimated $87.8K sold.

DSM Capital Partners first reported a position in TMO in Q4 2017 and held it in 18 quarters. The position peaked at $184M in Q3 2018. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • DSM Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • DSM Capital Partners sold 142 Thermo Fisher Scientific shares in Q4 2024, an estimated $87.8K.
  • DSM Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 18 quarters.
  • DSM Capital Partners's Thermo Fisher Scientific position peaked at $184M in Q3 2018.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on DSM Capital Partners's 13F filing for Q4 2024, filed 31 Jan 2025.